Advances in bronchopulmonary dysplasia

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Respiratory Medicine

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease affecting extremely premature infants.
• It remains a common and serious complication of premature birth, with unchanged incidence despite advances in neonatal care.
• The definition and understanding of BPD have evolved over the past four decades.

Purpose of the Study:

• To review the historical evolution of bronchopulmonary dysplasia (BPD) and its diagnostic criteria.
• To summarize current therapeutic strategies for managing BPD.
• To explore promising future investigational therapies for BPD, including stem cell-based approaches.

Main Methods:

• This review synthesizes existing literature on BPD.
• It examines the progression of diagnostic criteria and therapeutic interventions over time.
• Focus is placed on pharmacologic, supportive, and emerging stem cell-based therapies.

Main Results:

• Current management includes pharmacologic agents like methylxanthines, corticosteroids, and vitamin A.
• Supportive therapies focus on non-invasive ventilation and controlled oxygen delivery to minimize lung injury.
• Stem cell-based therapies represent a novel and promising avenue for BPD prevention and treatment.

Conclusions:

• Despite advances, BPD incidence remains a significant challenge in neonatal care.
• A combination of optimized supportive care and targeted pharmacologic treatments is crucial.
• Investigational therapies, particularly stem cell approaches, offer hope for improved BPD outcomes.